Monsanto, the leading developer and marketer of genetically engineered crops, says it won't commercialize technologies that render second- generation seeds sterile. Such "terminator" technologies have been a contentious issue in the intensifying debate surrounding genetically modified plants and foods. Although companies see such technologies as ways to protect and recoup their R&D investments through seed sales, opponents see them as a threat to farmers' centuries-old practice of collecting seeds from year to year for replanting, an economic necessity in developing countries. Monsanto will gain ownership of the technology through its still-pending acquisition of cottonseed producer Delta & Pine Land. The Scott, Miss.-based company jointly developed and patented the technology—still several years away from commercialization—through a cooperative R&D agreement with the Department of Agriculture's Agricultural Research Service (ARS). A U.S. patent was awarded in March 1998. Delta & Pine Land is free to do what it wants with the technology until the acquisition by Monsanto goes ...
No takes yet. Share an insight, caveat, or question.
ANN THAYER (1999) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: